A-C, HIF1α-GFP ODD reporter levels in KBM7 (A) and HeLa (B, C) cells exposed to 1% oxygen (B) or treated with 0.5 mM DMOG for 18 h (A, C). D, Immunoblot for HIF1α and PHD2 levels in wildtype or HIF1α-GFP ODD reporter HeLa cells treated with DMOG (DM) compared to untreated controls (Ct). E, F, Analysis of HIF1 transcriptional response in KMB7 cells measured by immunoblot for carbonic anhydrase 9 (CA9) levels (E), or by VEGF ELISA in supernatants following incubation in 21% or 1% oxygen for the indicated times (F). G, HIF1α-GFP ODD KBM7 cells were confirmed to be near-haploid using Propidium Iodide (PI) staining (left, solid black line = haploid WT KBM7 cells, green = HIF1α-GFP ODD KBM7 cells, dotted black = mixed haploid/diploid WT KBM7 cells), and mutagenised with the Z-loxP-mCherry genetrap retrovirus (right) . Approximately 80% of the cells were transduced with the virus. H, I, HIF1α-GFP ODD reporter cells were lentivirally transduced with Cas9 and sgRNA to PHD2, OGDH, LIAS or β2 microglobulin (β2m). sgRNA-mediated depletion of β2 microglobulin (β2m) was used as a negative control. HIF1α levels were measured by immunoblot (A). Flow cytometry analysis of cell surface MHC Class I levels confirmed β2m depletion (B, right).
CRISPR-Cas9 depletion of β2m had no effect on GFP levels in the HIF1α-GFP ODD 
A-C, Oxygen consumption rates (OCR) (A) and extracellular acidification rates (ECAR) (B, C)
were measured in HeLa cells depleted for PHD2, OGDH or LIAS. Measurements were performed using a Seahorse XF e 24 Extracellular Flux Analyzer (4 technical replicates per sample). Three basal measurements were made at 9 min intervals followed by three measurements per treatment (1µM oligomycin, 1µM FCCP and 1µM antimycin/rotenone).
OCR and ECAR were normalised to total cell protein content. ECAR were measured at baseline and following 1µM oligomycin treatment (B) and the percentage increase in ECAR following oligomycin measured (C). D-F OCR (D) and ECAR (E, F) measured in the PHD2, OGDH and LIAS null clones as described previously (n=3 
EXPERIMENTAL PROCEDURES

Metabolomic analyses
Liquid Chromatography Mass Spectrometry (LC-MS) analysis of sample extracts was performed on a QExactive Orbitrap mass spectrometer coupled to Dionex UltiMate 3000
Rapid Separation LC system (Thermo). The liquid chromatography system was fitted with a SeQuant Zic-pHILIC (150mm × 2.1mm, 5µm) with guard column (20mm × 2.1mm, 5µm) from Merck (Darmstadt, Germany). The mobile phase was composed of 20mM ammonium carbonate and 0.1% ammonium hydroxide in water (solvent A), and acetonitrile (solvent B).
The flow rate was set at 180µL x min -1 with the following gradient: 0 min 70% B, 1 min 70% B, 16 min 38% B, 16.5 min 70% B, hold at 70% B for 8.5 min. The mass spectrometer was operated in full MS and polarity switching mode. Five independent cell cultures were measured for each condition and samples were randomised in order to avoid bias in sample analyses due to machine drift. The acquired spectra were analysed using XCalibur Qual
Browser and XCalibur Quan Browser software (Thermo Scientific) by referencing to an internal library of compounds. R packages muma and gplots were used for data visualisation. Derivatisation of 2-HG metabolite extracts with diacetyl-L-tartaric anhydride (DATAN) was performed as previously described (Oldham et al., 2015; Struys et al., 2004 ) with some modifications. Briefly, for each sample, 200μl metabolite extract was evaporated to dryness at ambient temperature in a Savant SpeedVac Concentrator (Thermo Scientific). The residue was resuspended in 50μl freshly-mixed 80% acetonitrile/20% acetic acid plus 50mg/ml DATAN (Acros Organics) and heated at 75°C for 30 min. Samples were cooled to room temperature and centrifuged before addition of 50μl 80% acetonitrile/20% acetic acid.
5µL of derivatised sample was injected onto am Acquity UHPLC HSS T3 column (100 x 2.1mm, 1.8µm particle size). A Dionex UltiMate 3000 Rapid Separation LC was coupled to a Q Exactive Orbitrap mass spectrometer, and a gradient elution of 1.5mM ammonium formate in water (mobile phase A, pH 3.6 adjusted with formic acid) and 0.1% formic acid in acetonitrile (mobile phase B) was used to separate the derivatised L-and D-2HG enantiomers. The target analytes were monitored by in parallel-reaction monitoring (PRM) in negative electrospray ionization mode. The transition (precursor ion → product ion) of m/z 363 → 147 for derivatised D-and L-2-HG was monitored and the accurate mass of 147.03 was extracted using XCalibur Qual Browser and XCalibur Quan Browser software (Thermo Scientific), and used for relative quantification. Experimental samples were randomised in order to avoid bias in sample analyses due to machine drift.
Modelling of the OGDHC and lipoic acid synthesis proteins
All non-experimentally derived models were determined through use of the Phyre2 fold recognition server (Kelley et al., 2015) . The E1 subunit, OGDH (Uniprot id Q02218) was submitted to the Phyre2 server and a model was returned matching residues 36-975 (95% coverage), based on mycobacterium smegmatis alpha-ketoglutarate decarboxylase (PDB id 2XT6, 44% sequence identity). The E2 subunit, DLST (Uniprot id P36957), was modelled by considering each of its domains separately and submitting them to the Phyre2 server.
Residues 220-451, corresponding to the catalytic domain, were modelled based on the E. coli DLST catalytic domain (PDB id 1SCZ, 60% sequence identity). Residues 71-143, corresponding to the lipoyl domain, were modelled on the lipoyl domain of PDH kinase isoform 3 (PDB id 2Q8I, 40% identity). As the OGDHC shares its E3 subunit, DLD, with PDH, a crystal structure of this subunit, in the form of a dimeric biological assembly, was obtained from the PDB (id 1ZMD) and used directly to generate an image. Figures derived from these models were prepared by generating space-filling sphere based images using PyMOL.
Proteins involved in lipoic acid formation were modelled as for the OGDHC, and were generated via the Phyre2 server. ISCA2 (Uniprot id Q86U28) residues 49-153 were modelled on IscA from thermosynechococcus elongatus (PDB id 1X0G, 27% identity). The location of the [2Fe-2S] cluster was copied from that in the template structure by structural alignment using the super PyMOL command. BOLA3 (Uniprot id Q53S33) residues 33-107 were modelled on BolA2 from arabadopsis thaliana (PDB id 2MM9). An NMR model (PDB id 2M5O) exists for residues 162-247 of NFU1 and was used directly in visualisation. LIAS residues 70-357 were modelled on lipoyl synthase 2 from thermosynechococcus elongatus (PDB id 4U0O). To place the [4Fe-4S] clusters in the human LIAS model, the template and model were aligned to each other with the PyMOL align command and clusters copied to the human model.
Bioenergetic Profiling
OCR and ECAR measurements were performed using a Seahorse XF e 24 Extracellular Flux Analyzer. HeLa cells were seeded to Seahorse XF e 24 cell culture microplates and 1 h prior to analysis the medium was replaced with unbuffered DMEM (25mM glucose, 2mM Lglutamine, 1mM sodium pyruvate, 2% FCS). Measurements were performed as described by ECAR measurements were taken at 9 min intervals, followed by sequential treatments with 1μM oligomycin, 1μM FCCP and 1μM rotenone/1μM antimycin (three measurements each at 9 min intervals). Following analysis, the cells were lysed in 1% NP40 and the protein content of each well determined by Bradford protein assay to allow normalisation of OCR and ECAR values to cell protein content.
Patient Samples
Primary human fibroblast cell lines were kindly donated by Dr Johannes Mayr. The following cell lines have been published previously:
1) LIAS (NM_006859.2) c.746G>A (p.Arg249His), homozygous (Mayr et al., 2011) .
2) BOLA3 (NM_212552.2) c.200T>A (p.Ile67Asn), homozygous (published as patient #49720) (Haack et al., 2013 for an NFU1 mutation and the mutation c.544C>T was identified (published as patient 3) (Ahting et al., 2015) . At the level of genomic DNA this position was found to be heterozygous.
All coding exons were sequenced but a second mutation could not be identified. It is most likely the second allele results in an unstable mRNA, probably due to activation of a cryptic intronic splice site. ). An MRI revealed severe leukodystrophy already at age 7 months showing progression at age 22 months. This mutation has been previously described and seems to be a founder mutation in the Saudi population (Al-Hassnan et al., 2015) .
Two fibroblast control cells were used:
C1, This was obtained from a girl with HMGCL deficiency (NM_000191.2) causing abnormalities in ketone body formation (donated by Dr Mayr).
C2, Female patient obtained as a primary dermal fibroblast commercial sample from Lonza.
Plasmids
Full details of plasmids used are shown below. The majority of viral vectors were pHRSIN-based lentiviral plasmids (Demaison et al., 2002) . The HIF1α-GFP ODD reporter was generated by insertion of the HIF1α ODD (aa 530-603) at the 5' of EGFP in the pHRSIN EGFP vector. The SFFV promoter was substituted for the iNOS HRE minimal promotor region to form the pHRSIN HRE-HIF1α-GFP ODD plasmid. The LentiCRISPRv2 vector system was used for all CRISPR-Cas9 experiments (Sanjana et al., 2014) . 
Name Transgene Source
